US Patent 11977081 ANGPTL8 assay and uses thereof

Is a

Patent

Patent attributes

Patent Applicant

Regeneron Pharmaceuticals

Current Assignee

Regeneron Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119770810

Patent Inventor Names

Viktoria Gusarova0

Jesper Gromada0

Andrew J. Murphy0

Date of Patent

May 7, 2024

Patent Application Number

169549180

Date Filed

December 18, 2018

Patent Citations

‌

US Patent 10774139 ANGPTL8-binding agents and methods of use thereof

‌

US Patent 10442856 Methods of treating obesity with anti-ANGPTL8 antibodies

‌

US Patent 7157247 Secreted and transmembrane polypeptides and nucleic acids encoding the same

‌

US Patent 7244816 Secreted and transmembrane polypeptides and nucleic acids encoding the same

‌

US Patent 7368531 Human secreted proteins

‌

US Patent 7393663 Expressed sequence tags and encoded human proteins

‌

US Patent 10259870 Anti-ANGPTL8 antibodies and uses thereof

Patent Primary Examiner

‌

Gary Counts

Patent abstract

The present invention provides ELISA-based methods for detecting and/or quantifying ANGPTL8 in biological samples using anti-ANGPTL8 antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11977081 ANGPTL8 assay and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11977081 ANGPTL8 assay and uses thereof